Figure 3.
Chemical structures of anticancer drugs (A–G) and AgNPs capping agents (H–J) to mediate interaction between AgNPs and anticancer drugs. (A)—methotrexate; (B)—doxorubicin; (C)—alendronate; (D)—epirubicin; (E)—paclitaxel; (F)—imatinib; (G)—gemcitabine; (H)—folic acid; (I)—polyethyleneimine, branched; (J)—graphene oxide.